Navigation Links
Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
Date:12/21/2007

was developed at Lexicon as a potent inhibitor of tryptophan hydroxylase (TPH), a rate-limiting enzyme in the synthesis of serotonin. In preclinical studies, LX1032 was able to reduce peripheral serotonin in several different species without affecting serotonin levels in the brain. LX1032 is Lexicon's second compound to target TPH and, unlike LX1031, which acts locally within the gastrointestinal tract, was designed to act systemically.

LX1032 is being developed in a product development collaboration with Symphony Capital Partners, L.P. and its co-investors.

About Lexicon

Lexicon is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon currently has development programs underway for such areas of major unmet medical need as irritable bowel syndrome, cognitive disorders, and autoimmune diseases. The company has used its proprietary gene knockout technology to discover more than 100 promising drug targets and create an extensive pipeline of clinical and preclinical programs in the therapeutic areas of diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders and ophthalmic disease. To advance the development and commercialization of its programs, Lexicon is working both independently and through collaborators including Bristol-Myers Squibb Company, Genentech, Inc. and N.V. Organon. For additional information about Lexicon and its programs, please visit http://www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX1032 and the potential therapeutic and commercial potential of LX1032. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strate
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. Lexicon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Lexicon Appoints Judith Swain, M.D. to Board of Directors
4. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
5. Lexicon Pharmaceuticals to Present at Bio InvestorForum
6. Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
7. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
8. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
9. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... the latest particle size distribution technologies, including the new C35 ... AAPS 2010. , ... (PRWEB) December ... American Association of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010 ... Booth 612 at AAPS 2010 to see the latest particle ...
(Date:12/16/2009)... have developed a simple, cheap, accurate test to find ... have created a custom-made bacteria that glows green when ... explosives. , The bacteria can be mixed into a ... forms green patches to indicate the presence of landmines. ... cheap to produce, could be delivered from the air ...
(Date:12/16/2009)... from roadside bombs to freeway crashes. Traumatic injury, the ... 44, often overwhelms the body,s natural blood-clotting process. , ... team led by Erin Lavik, a new Case Western ... student, James P. Bertram, built synthetic platelets that show ... is published in Science Translational Medicine ., The ...
(Date:12/16/2009)... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... that it will be launching the Human MicroRNA ... using its SmartChip(TM) Real-Time PCR System. The ... microRNA panel of 885 microRNAs on a single ... the use of its proprietary SmartChip Real-Time PCR ...
Breaking Biology Technology:Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2Researchers take the inside route to halt bleeding 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4
... MOUNTAIN VIEW, Calif., Oct. 14 Clontech Laboratories,Inc., ... the three,winners of the 2008 Nobel Prize in ... Tsien, for the discovery and development of the ... related fluorescent proteins.,The application of fluorescent proteins as ...
... divisions that include in vitro diagnostics, cancer therapeutics and ... ... Oct. 14 ( http://www.amdl.com ),AMDL, Inc. (Amex: ADL ), ... US, today announced it has restructured,its business into three distinct divisions ...
... Oct. 14 Nyer Medical Group,Inc. (Nasdaq: NYER ) ... for the fiscal year ended June 30, 2008 increased $6.6,million ... for the,previous fiscal year. Net loss for the fiscal year ... compared to a net income of $86,446 or $.02,per share ...
Other Biology Technology:Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry 2AMDL, Inc. Announces Strategic Realignment 2AMDL, Inc. Announces Strategic Realignment 3Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008 2Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008 3
(Date:12/16/2009)... financial and technical assistance to developing countries around the ... be connected to space technology, but large development projects ... , Global climate change is also an increasingly important ... poorest countries and communities, which will suffer the earliest ... a growing demand for information about the state of ...
(Date:12/16/2009)... 15, 2009 Signal Hill, CA Tom Bowman, ... and president of Bowman Global Change, has developed a ... fourth Intergovernmental Panel on Climate Change (IPCC) report for ... the authentic scientific information they need to make informed ... created the new format as a means to clearly ...
(Date:12/16/2009)... Calif. and PALM HARBOR, Fla., Dec. 2 ... Bulletin Board: CICI), a leading supplier of ... in the financial industry* and the recognized ... Systems Inc. ("Docubase"), a leading International Electronic ... that they have entered an agreement to ...
Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Bowman creates graphic translation of climate change data 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 1Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 2Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 3Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 4Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec 51435 1Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec 51435 2Victory Pharma Inc Announces FDA Accepts MGX006 NDA for Review 51430 1Victory Pharma Inc Announces FDA Accepts MGX006 NDA for Review 51430 2
... time when peeking at another student,s work during class ... when only televisions had clickers, not classrooms. , Starting ... biology lab sections at Worcester Polytechnic Institute (WPI) have ... that promises to improve student-achievement and enhance teaching during ...
... the waning months of the First World War, a ... subtype H1N1), swept the United States, Europe and Asia ... ensuing pandemic claimed up to 100 million victims, most ... rapidly progressing pneumonia. Many died within days of the ...
... the elevated carbon dioxide (CO 2 ) levels predicted for ... atmospheric conditions, researchers report, a finding that will help fine-tune ... CO 2 levels rise. , The study, from researchers ... Agriculture, appears this week in the Proceedings of the ...
Other Biology News:At WPI, some students are learning it's OK to peek 2At WPI, some students are learning it's OK to peek 3At WPI, some students are learning it's OK to peek 4Shades of 1918? New study compares avian flu with a notorious killer from the past 2Shades of 1918? New study compares avian flu with a notorious killer from the past 3Shades of 1918? New study compares avian flu with a notorious killer from the past 4Shades of 1918? New study compares avian flu with a notorious killer from the past 5High CO2 boosts plant respiration, potentially affecting climate and crops 2
...
Use as the souce of CETP enzyme for screening CETP inhibitors. Use in conjunction with the CETP activity assay kit (K601-100)....
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
22 x 50 mm; No. 1 thickness range: 0.13 to 0.17 mm, suitable for work in histology, cytology, urinalysis and microbiology, precleaned, store at room temperature ...
Biology Products: